The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Zhendi Wang,3 Fang Zeng,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for...

Full description

Bibliographic Details
Main Authors: Cheng F, Li Q, Wang J, Wang Z, Zeng F, Zhang Y
Format: Article
Language:English
Published: Dove Medical Press 2021-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/the-effects-of-oral-sodium-bicarbonate-on-renal-function-and-cardiovas-peer-reviewed-fulltext-article-TCRM
_version_ 1818426133595553792
author Cheng F
Li Q
Wang J
Wang Z
Zeng F
Zhang Y
author_facet Cheng F
Li Q
Wang J
Wang Z
Zeng F
Zhang Y
author_sort Cheng F
collection DOAJ
description Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Zhendi Wang,3 Fang Zeng,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, People’s Republic of China; 3Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Fang Zeng; Yu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaEmail fancyzeng@126.com; zhangwkp@163.comObjective: Oral sodium bicarbonate is often used to correct acid-base disturbance in patients with chronic kidney disease (CKD). However, there is little evidence on patient-level benign outcomes to support the practice.Methods: We conducted a systematic review and meta-analysis to examine the efficacy and safety of oral sodium bicarbonate in CKD patients. A total of 1853 patients with chronic metabolic acidosis or those with low-normal serum bicarbonate (22– 24 mEq/L) were performed to compare the efficacy and safety of oral sodium bicarbonate in patients with CKD.Results: There was a significant increase in serum bicarbonate level (MD 2.37 mEq/L; 95% CI, 1.03 to 3.72) and slowed the decline in estimated glomerular filtration rate (eGFR) (MD − 4.44 mL/min per 1.73 m2, 95% CI, − 4.92 to − 3.96) compared with the control groups. The sodium bicarbonate lowered T50-time, an indicator of vascular calcification (MD − 20.74 min; 95% CI, − 49.55 to 8.08); however, there was no significant difference between the two groups. In addition, oral sodium bicarbonate dramatically reduced systolic blood pressure (MD − 2.97 mmHg; 95% CI, − 5.04 to − 0.90) and diastolic blood pressure (MD − 1.26 mmHg; 95% CI, − 2.33 to − 0.19). There were no statistically significant body weight, urine pH and mean mid-arm muscle circumference.Conclusion: Treatment of metabolic acidosis with sodium bicarbonate may slow the decline rate of kidney function and potentially significantly improve vascular endothelial function in patients with CKD.Prospero Registration Number: CRD42020207185.Keywords: chronic kidney disease, metabolic acidosis, sodium bicarbonate, kidney function, cardiovascular risk
first_indexed 2024-12-14T14:24:59Z
format Article
id doaj.art-d0b54a9f6b10404ea9ec7723d9fd9051
institution Directory Open Access Journal
issn 1178-203X
language English
last_indexed 2024-12-14T14:24:59Z
publishDate 2021-12-01
publisher Dove Medical Press
record_format Article
series Therapeutics and Clinical Risk Management
spelling doaj.art-d0b54a9f6b10404ea9ec7723d9fd90512022-12-21T22:57:59ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2021-12-01Volume 171321133171262The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-AnalysisCheng FLi QWang JWang ZZeng FZhang YFang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Zhendi Wang,3 Fang Zeng,1,2 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, People’s Republic of China; 3Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Fang Zeng; Yu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaEmail fancyzeng@126.com; zhangwkp@163.comObjective: Oral sodium bicarbonate is often used to correct acid-base disturbance in patients with chronic kidney disease (CKD). However, there is little evidence on patient-level benign outcomes to support the practice.Methods: We conducted a systematic review and meta-analysis to examine the efficacy and safety of oral sodium bicarbonate in CKD patients. A total of 1853 patients with chronic metabolic acidosis or those with low-normal serum bicarbonate (22– 24 mEq/L) were performed to compare the efficacy and safety of oral sodium bicarbonate in patients with CKD.Results: There was a significant increase in serum bicarbonate level (MD 2.37 mEq/L; 95% CI, 1.03 to 3.72) and slowed the decline in estimated glomerular filtration rate (eGFR) (MD − 4.44 mL/min per 1.73 m2, 95% CI, − 4.92 to − 3.96) compared with the control groups. The sodium bicarbonate lowered T50-time, an indicator of vascular calcification (MD − 20.74 min; 95% CI, − 49.55 to 8.08); however, there was no significant difference between the two groups. In addition, oral sodium bicarbonate dramatically reduced systolic blood pressure (MD − 2.97 mmHg; 95% CI, − 5.04 to − 0.90) and diastolic blood pressure (MD − 1.26 mmHg; 95% CI, − 2.33 to − 0.19). There were no statistically significant body weight, urine pH and mean mid-arm muscle circumference.Conclusion: Treatment of metabolic acidosis with sodium bicarbonate may slow the decline rate of kidney function and potentially significantly improve vascular endothelial function in patients with CKD.Prospero Registration Number: CRD42020207185.Keywords: chronic kidney disease, metabolic acidosis, sodium bicarbonate, kidney function, cardiovascular riskhttps://www.dovepress.com/the-effects-of-oral-sodium-bicarbonate-on-renal-function-and-cardiovas-peer-reviewed-fulltext-article-TCRMchronic kidney diseasemetabolic acidosissodium bicarbonatekidney functioncardiovascular risk
spellingShingle Cheng F
Li Q
Wang J
Wang Z
Zeng F
Zhang Y
The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Therapeutics and Clinical Risk Management
chronic kidney disease
metabolic acidosis
sodium bicarbonate
kidney function
cardiovascular risk
title The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
title_full The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
title_fullStr The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
title_full_unstemmed The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
title_short The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
title_sort effects of oral sodium bicarbonate on renal function and cardiovascular risk in patients with chronic kidney disease a systematic review and meta analysis
topic chronic kidney disease
metabolic acidosis
sodium bicarbonate
kidney function
cardiovascular risk
url https://www.dovepress.com/the-effects-of-oral-sodium-bicarbonate-on-renal-function-and-cardiovas-peer-reviewed-fulltext-article-TCRM
work_keys_str_mv AT chengf theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT liq theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT wangj theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT wangz theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT zengf theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT zhangy theeffectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT chengf effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT liq effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT wangj effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT wangz effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT zengf effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis
AT zhangy effectsoforalsodiumbicarbonateonrenalfunctionandcardiovascularriskinpatientswithchronickidneydiseaseasystematicreviewandmetaanalysis